Rational Drug Design Is An Approach To Discovering New Medications That Relies On Principles Of Molecular Modeling. This Method Of Drug Discovery Has Revolutionized The Pharmaceutical Industry By Providing A Systematic Approach To Understanding How Drugs Interact With Their Biological Targets, Enabling More Rapid And Effective Development Of New Treatments. The Rational Drug Design Process Begins With The Identification Of Molecular Targets Involved In A Disease Or Other Condition. This Target Is Then Studied To Determine Its Three-Dimensional Structure And How It Interacts With Compounds. The Structure Is Then Reproduced In A Computer Model, And Various Compounds Are Simulated To See Which Ones Bind To The Target With The Greatest Affinity. These Compounds Can Then Be Tested In Clinical Trials To Assess Their Efficacy And Safety In The Body. Rational Drug Design Has Significant Advantages Over Traditional Drug Discovery Methods. Most Notably, It Focuses On A Molecular Target Known To Be Involved In A Condition, Meaning That Medications Are Designed With A Much Greater Likelihood Of Being Effective. In Addition, Rational Drug Design Can Significantly Reduce The Amount Of Time Required For Drug Development And Reduce The Number Of Compounds Required For Testing. The Main Disadvantage To Rational Drug Design Is The Cost Associated With Creating And Testing The Computer Models. It Is Also A Fairly New Technology, And Therefore A Larger Amount Of Research And Development Must Be Conducted To Ensure The Accuracy Of The Models. In Addition, This Type Of Approach May Not Be Feasible For Some Conditions, As The Molecular Target Involved May Be Unknown Or Impossible To Model. Despite Its Challenges, Rational Drug Design Has Greatly Improved The Speed And Efficacy Of Drug Delivery. As Technology Further Develops, This Approach Will Continue To Be An Invaluable Method For Developing New Treatments For A Variety Of Conditions.
Title : Fighting antibiotic resistance: Eliminating implant infections in humans without antibiotics
Thomas Jay Webster, Brown University, United States
Title : Direct solar leaf-dehydration: physiochemistry, and practice on the island of Crete
Victor John Law, University College Dublin, Ireland
Title : Tomographic image of molecules based on spin-spin interactions that are part of them resonating nuclei of atoms
Vladimir Voronov, Irkutsk National Research Technical University, Russian Federation
Title : PH-dependent recoil stabilization in Iodates following the (n,gamma) process
Shree Niwas Chaturvedi, Centre for Aptitude Analysis and Talent Search, Heritage School, Buxar, India
Title : Antibacterial activity of bioactive compounds extracted from the Egyptian untapped green algae Rhizoclonium hieroglyphicum
Ahmed Diab Mohamed Ahmed El Esawy, Drinking Water and Sanitation Company, Egypt
Title : Study of hydrogen transfer reactions within the framework of the non-equilibrium approach
I A Romanskii, N N Semenov Institute of Chemical Physics, Russian Federation